Year: 2021

Joint Stock Company “Olainfarm” hereby informs that today, 7th December 2021 at 16:00 JSC AB CITY will end the mandatory share repurchase offer process. Repurchase price is EUR 9.26 (nine euros and 26 cents) for one share.Additional information: Jānis Leimanis JSC Olainfarm Management board member Phone: +371 29269424 Email: janis.leimanis@olainfarm.com

Verizon Connect findings reveal 86% of European Fleets achieve Return on Investment within a year or less and improved customer service DUBLIN, Ireland, Dec. 07, 2021 (GLOBE NEWSWIRE) — The critical link between the use of fleet management technology in achieving Return on Investment (ROI) and improving customer service has been reinforced through European survey findings sponsored by Verizon Connect. The survey conducted by ABI Research was completed by more than 1,350 European fleet managers, executives and other mobile business professionals in 10 countries1. Seventy-four percent of respondents found using fleet management technology was ‘very’ and ‘extremely’ beneficial to their business; with 86% witnessing ROI within a year or less, and just under half (44%) experiencing this within six months or less. Importantly for long-term...

Refurbishment processDecember 7, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has been recognized for its climate action leadership by global environmental non-profit CDP. Thanks to its actions to cut emissions, mitigate climate risks, and develop the low-carbon economy, Philips has secured a place on CDP’s ‘A List’ for the ninth consecutive year. “With health systems and consumers increasingly committed to making more sustainable choices and to climate action, we remain convinced that doing business sustainably is the only way forward,” said Frans van Houten, CEO of Royal Philips. “Our ongoing actions to embed sustainability in our solutions, our operations and across the supply chain, have once again been recognized with...

EMA’s CHMP recommended the approval yesterday Approval based on results from four phase III studies in over 5,500 patients Actemra/RoActemra has also been provisionally approved in Australia for the treatment of COVID-19Basel, 07 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This decision comes just hours after the recommendation by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), reflecting the urgent need for Actemra/RoActemra as a potential treatment option during the COVID-19 public health emergency. “Actemra/RoActemra...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) — Search Minerals Inc. (“Search” or the “Company”) (TSXV: SMY | OTCQB: SHCMF is pleased to update the terms of the Company’s non-brokered private placement of flow-through common shares of the Company (“the “FT Shares”), as announced on December 3, 2021 (the “FT Offering”). The Company is pleased to announce that Search will complete a non-brokered private placement offering for aggregate gross proceeds of up to $15,000,000, through a combination of (i) FT Shares at a price of $0.25 per FT Share, up to a maximum of $5,000,000; and (ii) units of the Company (the “Units“) at a price of $0.18 per Unit (the “Unit Offering“). Each...

Report details AI/ML benefits to complex encode and decode and vital operations across the video supply chain WILMINGTON, Del., Dec. 07, 2021 (GLOBE NEWSWIRE) — Often considered a “solution for everything,” AI will expand its impact as the video entertainment industry realizes its benefits to a variety of applications. A recent white paper commissioned by InterDigital, Inc. (NASDAQ: IDCC) and written by market research firm Futuresource Consulting examines the industry influence of artificial intelligence (AI) and machine learning (ML) on applications across the video supply chain. The report, “AI and Machine Learning in the Video Industry: New Opportunities for the Entertainment Sector,” investigates the emerging uses of AI across segments of the media industry and highlights key examples of how AI is employed today and might...

–Company to Host Conference Call on Tuesday, December 7, 2021, at 8:30 am ET– SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) announced that Management will host a conference call at 8:30 am ET, Tuesday, December 7, 2021, to discuss new data that demonstrates sotrovimab retains activity against the full combination of mutations in the spike protein of the Omicron SARS-CoV-2 variant. To access the call via telephone, please dial (833) 727-9519 (North America) or (830) 213-7696 (International), conference ID: 9894016. A live webcast of the call can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days. About Vir BiotechnologyVir Biotechnology is a commercial-stage immunology company focused on...